fadrozole has been researched along with Experimental Mammary Neoplasms in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (20.00) | 18.7374 |
| 1990's | 8 (80.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bartz, U; Bayer, H; Grün, G; Hartmann, RW; Mitrenga, M; Sergejew, T | 1 |
| Tsukagoshi, S | 1 |
| Brodie, A; Savinov, A; Wang, J; Yue, W | 1 |
| Hasegawa, Y; Nakao, K; Tanaka, M; Yano, S | 1 |
| Durgam, VR; Tekmal, RR | 1 |
| Horiuchi, R; Iino, Y; Maemura, M; Morishita, Y; Owada, S; Sato, H; Sugamata, N; Tago, T; Yokoe, T | 1 |
| Hayashi, K; Kosaki, G; Shimozuma, K; Tominaga, T; Yoshida, Y | 1 |
| Bhatnagar, AS; Bowman, R; Häusler, A; Lang, M; Schieweck, K | 1 |
| el Etreby, MF; Michna, H; Nishino, Y; Schneider, MR | 1 |
| Bhatnagar, AS; Matter, A; Schieweck, K | 1 |
1 review(s) available for fadrozole and Experimental Mammary Neoplasms
| Article | Year |
|---|---|
Highly selective inhibition of estrogen biosynthesis by CGS 20267, a new non-steroidal aromatase inhibitor.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Aromatase Inhibitors; Estrogen Antagonists; Estrogens; Fadrozole; Imidazoles; Letrozole; Mammary Neoplasms, Experimental; Nitriles; Steroids; Triazoles | 1990 |
1 trial(s) available for fadrozole and Experimental Mammary Neoplasms
| Article | Year |
|---|---|
[Introduction of a new aromatase inhibitor fadrozole hydrochloride hydsate].
Topics: Animals; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Estrogen Antagonists; Fadrozole; Female; Humans; Mammary Neoplasms, Experimental; Rats | 1995 |
8 other study(ies) available for fadrozole and Experimental Mammary Neoplasms
| Article | Year |
|---|---|
Pyridyl-substituted tetrahydrocyclopropa[a]naphthalenes: highly active and selective inhibitors of P450 arom.
Topics: Adrenal Glands; Animals; Antineoplastic Agents; Aromatase Inhibitors; Cattle; Female; Humans; Liver; Male; Mammary Neoplasms, Experimental; Naphthalenes; Ovary; Placenta; Pyridines; Rats; Testis | 1995 |
Effect of aromatase inhibitors on growth of mammary tumors in a nude mouse model.
Topics: Androstenedione; Animals; Antineoplastic Agents; Aromatase Inhibitors; Cell Division; Fadrozole; Female; Letrozole; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Mice, Nude; Nitriles; Organ Size; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen; Triazoles; Uterus | 1995 |
Antiproliferative effect of the new aromatase inhibitor fadrozole on pre- and postmenopausal models of rat mammary tumor.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Androstenedione; Animals; Antineoplastic Agents; Aromatase Inhibitors; Fadrozole; Female; Hormones; Mammary Neoplasms, Experimental; Menopause; Ovariectomy; Rats; Rats, Sprague-Dawley | 1994 |
A novel in vitro and in vivo breast cancer model for testing inhibitors of estrogen biosynthesis and its action using mammary tumor cells with an activated int-5/aromatase gene.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Aminoglutethimide; Analysis of Variance; Anastrozole; Androstenedione; Animals; Antineoplastic Agents, Hormonal; Aromatase; Aromatase Inhibitors; Breast Neoplasms; Cell Division; Enzyme Inhibitors; Fadrozole; Female; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Humans; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Mice, Nude; Nitriles; Ovariectomy; Postmenopause; Triazoles; Tumor Cells, Cultured | 1997 |
Antitumor effects of a nonsteroidal aromatase inhibitor (CGS 16949A) on 7, 12-dimethylbenz[alpha]anthracene-induced mammary tumors in rats.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Antineoplastic Agents; Aromatase Inhibitors; Body Weight; Estradiol; Estrone; Fadrozole; Female; Imidazoles; Mammary Neoplasms, Experimental; Nitriles; Organ Size; Progesterone; Rats; Rats, Inbred Strains; Receptors, Estrogen; Testosterone; Uterus | 1991 |
Effect of CGS 16949A plus tamoxifen on induced mammary tumours in rats.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Antineoplastic Combined Chemotherapy Protocols; Dose-Response Relationship, Drug; Estradiol; Estrogen Antagonists; Estrone; Fadrozole; Female; Follicle Stimulating Hormone; Imidazoles; Luteinizing Hormone; Mammary Neoplasms, Experimental; Nitriles; Prolactin; Rats; Rats, Inbred Strains; Tamoxifen | 1990 |
Antitumor effect of a specific aromatase inhibitor, 1-methyl-androsta-1,4-diene-3,17-dione (atamestane), in female rats bearing DMBA-induced mammary tumors.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Androstenedione; Animals; Antineoplastic Agents; Aromatase Inhibitors; Fadrozole; Female; Imidazoles; Mammary Neoplasms, Experimental; Nitriles; Rats; Rats, Inbred Strains | 1989 |
CGS 16949A, a new nonsteroidal aromatase inhibitor: effects on hormone-dependent and -independent tumors in vivo.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Aminoglutethimide; Animals; Aromatase Inhibitors; Body Weight; Cell Line; Drug Screening Assays, Antitumor; Fadrozole; Female; Imidazoles; Mammary Neoplasms, Experimental; Nitriles; Rats; Tamoxifen | 1988 |